Page last updated: 2024-11-05
tranexamic acid and Neoplasms, Skull Base
tranexamic acid has been researched along with Neoplasms, Skull Base in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Tranexamic acid was introduced during these procedures in 2006." | 1.43 | Use of Tranexamic Acid Is Associated with Reduced Blood Product Transfusion in Complex Skull Base Neurosurgical Procedures: A Retrospective Cohort Study. ( Akagami, R; Flexman, AM; Mebel, D, 2016) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Mebel, D | 1 |
| Akagami, R | 1 |
| Flexman, AM | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery: A Double-Blind Randomized Controlled Trial[NCT04863339] | Phase 2 | 0 participants (Actual) | Interventional | 2022-03-31 | Withdrawn (stopped due to Challenges in recruitment) |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for tranexamic acid and Neoplasms, Skull Base